Single of CNCT19 is named as a drug or biological intervention in 3 clinical trials in our China trial register, 3 of which are recruiting. The lead sponsor is Juventas Cell Therapy Ltd.. Registered phases: Phase 2 and Phase EARLY_PHASE1. Conditions studied include Relapsed or Refractory Acute Lymphoblastic Leukemia; Lupus Erythematosus, Systemic; Non-Hodgkin's Lymphoma.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06316791 | Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases (ClinicalTrials.gov ↗) Lupus Erythematosus, Systemic |
Phase EARLY_PHASE1 | Recruiting |
| NCT04586478 | Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (ClinicalTrials.gov ↗) Non-Hodgkin's Lymphoma |
Phase 2 | Recruiting |
| NCT04684147 | Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (ClinicalTrials.gov ↗) Relapsed or Refractory Acute Lymphoblastic Leukemia |
Phase 2 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Relapsed or Refractory Acute Lymphoblastic Leukemia | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Non-Hodgkin's Lymphoma | 1 |
| Lead sponsor | Trials |
|---|---|
| Juventas Cell Therapy Ltd. | 3 |
| Register | Single of CNCT19 trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Single of CNCT19 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Single of CNCT19 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.